Increased [qnco]
plasma concentration [qnco]
hormone replacement [topp]
therapy [ftcn]
objectives [inpr]
Design [acty]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Dominant [ftcn]
Role [socb]
Transforming Growth Factor beta [aapp, bacs]
Coronary Arteries [bpoc]
PROPOSED [idcn]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Block [patf]
Activation [acty]
Latent [qlco]
GIVEN [cnce]
Background [cnce]
Examined [fndg]
effects [qlco]
Hormone replacement therapy [topp]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
postmenopausal [tmco]
Women [popg]
Women [popg]
Documented [hlca]
coronary heart disease [dsyn]
randomized [resa]
Sequential [idcn]
Transdermal [ftcn]
weeks [tmco]
Then [tmco]
Medroxyprogesterone [horm, phsu, strd]
days [tmco]
Hormone replacement therapy [topp]
Control Group [grup]
[c] [qnco]
Result [ftcn]
Serum [bdsu]
Level [qlco]
Increased [qnco]
Hormone replacement therapy [topp]
Group [idcn]
Compared [acty]
c group [clas]
treatment [ftcn]
Effect [qlco]
Sustained [ftcn]
months [tmco]
reduction [npop]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Serum [bdsu]
Level [qlco]
treatment [ftcn]
Hormone replacement therapy [topp]
Group [idcn]
Compared [acty]
c group [clas]
months [tmco]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Serum [bdsu]
Level [qlco]
Detected [fndg]
Two [qnco]
Group [idcn]
Conclusion [idcn]
Novel [tmco]
Observation [resa]
Transdermal [ftcn]
postmenopausal [tmco]
Women [popg]
Increase [ftcn]
Levels [qlco]
Lower [spco]
Concentration [menp]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Suggest [idcn]
Possible [qlco]
Mechanism [ftcn]
Effect [qlco]
Hormone replacement therapy [topp]
Combination Therapy [topp]
Estradiol [horm, phsu, strd]
Effect [qlco]
Estradiol [horm, phsu, strd]
effects [qlco]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
